Metastasis inhibition in breast cancer by targeting cancer cell extravasation

Márcia R Cominetti1, Wanessa F Altei2, Heloisa Sobreiro Selistre-de-Araujo2

  • 1Department of Gerontology, Federal University of São Carlos, São Carlos, SP, Brazil.

Insights

Metastasis, the spread of cancer cells, causes most cancer deaths. This review details the metastatic cascade and strategies to inhibit cancer cell extravasation, focusing on breast cancer research.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Metastasis is the primary cause of cancer mortality, involving tumor cell dissemination from primary sites to distant organs.
  • The metastatic cascade includes tumor cell detachment, invasion, intravasation, circulation, extravasation, and colonization.
  • Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are critical cellular processes during metastasis.

Purpose of the Study:

  • To review the key stages of the metastatic cascade.
  • To explore strategies for inhibiting metastasis, specifically targeting cancer cell extravasation.
  • To present recent findings in the context of breast cancer metastasis.

Main Methods:

  • Literature review of the metastatic cascade.
  • Analysis of recent studies on metastasis inhibition strategies.
  • Focus on mechanisms reducing cancer cell extravasation.

Main Results:

  • Detailed description of the steps involved in tumor cell metastasis.
  • Identification of therapeutic strategies aimed at blocking cancer cell extravasation.
  • Highlighting advancements in understanding and potentially treating breast cancer metastasis.

Conclusions:

  • Understanding the metastatic cascade is crucial for developing effective cancer therapies.
  • Inhibiting cancer cell extravasation presents a promising therapeutic avenue.
  • Further research, particularly in breast cancer, can lead to improved patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K